-
4321
Clinical image: rare localization of a giant recurrent malignant meningioma
Published 2014-05-01“…Meningiomas are the most common benign brain tumors. Malignant meningioma is a rare subtype with a high recurrence rate and poor prognosis. …”
Get full text
Article -
4322
Three-Dimensional Dosimetry by Optical-CT and Radiochromic Gel Dosimeter of a Multiple Isocenter Craniospinal Radiation Therapy Procedure
Published 2022-09-01“…Craniospinal irradiation (CSI) is a complex radiation technique employed to treat patients with primitive neuroectodermal tumors such as medulloblastoma or germinative brain tumors with the risk of leptomeningeal spread. …”
Get full text
Article -
4323
The Combined Use of 5-ALA and Chlorin e6 Photosensitizers for Fluorescence-Guided Resection and Photodynamic Therapy under Neurophysiological Control for Recurrent Glioblastoma in...
Published 2022-03-01“…The treatment of glial brain tumors is an unresolved problem in neurooncology, and all existing methods (tumor resection, chemotherapy, radiotherapy, radiosurgery, fluorescence diagnostics, photodynamic therapy, etc.) are directed toward increasing progression-free survival for patients. …”
Get full text
Article -
4324
Translational Regulation by hnRNP H/F Is Essential for the Proliferation and Survival of Glioblastoma
Published 2022-03-01“…Deregulation of mRNA translation is a widespread characteristic of glioblastoma (GBM), aggressive malignant brain tumors that are resistant to conventional therapies. …”
Get full text
Article -
4325
PLGA Nanoparticle-Based Formulations to Cross the Blood–Brain Barrier for Drug Delivery: From R&D to cGMP
Published 2021-04-01“…The blood–brain barrier (BBB) is a natural obstacle for drug delivery into the human brain, hindering treatment of central nervous system (CNS) disorders such as acute ischemic stroke, brain tumors, and human immunodeficiency virus (HIV)-1-associated neurocognitive disorders. …”
Get full text
Article -
4326
Intracranial Efficacy of Systemic Therapy in Patients with Asymptomatic Brain Metastases from Lung Cancer
Published 2023-06-01“…We analyzed 96 patients with asymptomatic small-sized metastatic brain tumors from lung cancer. These underwent a radiologic follow-up every 2 or 3 months without local treatment of brain metastases. …”
Get full text
Article -
4327
Energy Metabolism in <i>IDH1</i> Wild-Type and <i>IDH1</i>-Mutated Glioblastoma Stem Cells: A Novel Target for Therapy?
Published 2021-03-01“…In the present review, we describe ATP production in primary brain tumors, glioblastoma, in relation to ROS production. …”
Get full text
Article -
4328
Genetic variants in XPD gene and glioma susceptibility in Chinese children: A multicenter case–control study
Published 2022-06-01“…Abstract Background Glioma is one of the central nervous system (CNS) tumors in children, accounting for 80% of malignant brain tumors. Nucleotide excision repair (NER) is a vital pathway during DNA damage repair progression. …”
Get full text
Article -
4329
Epigenetic-Based Therapy—A Prospective Chance for Medulloblastoma Patients’ Recovery
Published 2021-05-01“…Medulloblastoma (MB) is one of the most frequent and malignant brain tumors in children. The prognosis depends on the advancement of the disease and the patient’s age. …”
Get full text
Article -
4330
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target?
Published 2023-12-01“…The telomerase reverse transcriptase gene (<i>TERT</i>) is the most frequently altered gene in solid tumors, including brain tumors and GBM <i>IDH</i>-wildtype. In particular, it can be observed in approximately 80–90% of GBM <i>IDH</i>-wildtype cases. …”
Get full text
Article -
4331
Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling
Published 2022-11-01“…Glioblastoma (GBM) is the most malignant glioma in brain tumors with low survival and high recurrence rate. …”
Get full text
Article -
4332
Stem Cells in Clinical Trials on Neurological Disorders: Trends in Stem Cells Origins, Indications, and Status of the Clinical Trials
Published 2022-09-01“…The most common neurological disorders treated with stem cells were injuries of brain, spinal cord, and peripheral nerves (14%), stroke (13%), multiple sclerosis (12%), and brain tumors (11%). Mesenchymal stem cells dominated (83%) although the choice of stem cells was highly dependent on the neurological disorder. …”
Get full text
Article -
4333
The emerging role of pyroptosis in pediatric cancers: from mechanism to therapy
Published 2022-10-01“…Herein, we aimed to describe the molecular mechanisms of pyroptosis, to highlight and discuss the challenges and opportunities for activating pyroptosis pathways through various oncologic therapies in multiple pediatric neoplasms, including osteosarcoma, neuroblastoma, leukemia, lymphoma, and brain tumors.…”
Get full text
Article -
4334
A Simple 3D Cell Culture Method for Studying the Interactions between Human Mesenchymal Stromal/Stem Cells and Patients Derived Glioblastoma
Published 2023-02-01“…We have developed a 3D biosphere model using patient-derived cells (PDCs) from glioblastoma (GBM), the major form of primary brain tumors in adult, plus cancer-activated fibroblasts (CAFs), obtained by culturing mesenchymal stem cells with GBM conditioned media. …”
Get full text
Article -
4335
Role of Notch Signaling Pathway in Glioblastoma Multiforme Pathogenesis
Published 2019-03-01“…Therefore, genetic and functional alterations to NSCs can lead to the development of brain tumors, including glioblastoma multiforme (GBM). …”
Get full text
Article -
4336
Advanced Pediatric Diffuse Pontine Glioma Murine Models Pave the Way towards Precision Medicine
Published 2021-03-01“…Diffuse intrinsic pontine gliomas (DIPGs) account for ~15% of pediatric brain tumors, which invariably present with poor survival regardless of treatment mode. …”
Get full text
Article -
4337
Emerging Pathogenic and Prognostic Significance of Paired Box 3 (PAX3) Protein in Adult Gliomas
Published 2019-10-01“…Gliomas present the most common type of brain tumors in adults, characterized by high morbidity and mortality. …”
Get full text
Article -
4338
Profiling of Carnitine Shuttle System Intermediates in Gliomas Using Solid-Phase Microextraction (SPME)
Published 2021-10-01“…The current study aims to assess the profiles of carnitine and acylcarnitines in gliomas with respect to their grade, the presence of isocitrate dehydrogenase (IDH) mutations, and 1p/19q co-deletion. Brain tumors obtained from 19 patients were sampled on-site using solid-phase microextraction (SPME) immediately following excision. …”
Get full text
Article -
4339
Transcranial Photosensitizer-Free Laser Treatment of Glioblastoma in Rat Brain
Published 2023-09-01“…Over sixty years, laser technologies have undergone a technological revolution and become one of the main tools in biomedicine, particularly in neuroscience, neurodegenerative diseases and brain tumors. Glioblastoma is the most lethal form of brain cancer, with very limited treatment options and a poor prognosis. …”
Get full text
Article -
4340
Ion Channels in Gliomas—From Molecular Basis to Treatment
Published 2023-01-01“…Targeting ion channels in difficult-to-treat brain tumors such as gliomas requires an understanding of their extremely heterogenous tumor microenvironment and highly diverse molecular profiles, both representing major causes of recurrence and treatment resistance. …”
Get full text
Article